Identifying Extended-Release Naltrexone Treatment for Opioid Use Disorder in US Medicaid Data.
Saved in:
| Title: | Identifying Extended-Release Naltrexone Treatment for Opioid Use Disorder in US Medicaid Data. |
|---|---|
| Authors: | Ross RK; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA., Butler AM; Division of Infectious Diseases, John T. Milliken Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA., Seamans MJ; Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, California, USA., Williams AR; Department of Psychiatry, Columbia University, New York, New York, USA.; New York State Psychiatric Institute, New York, New York, USA., Samples H; Center for Pharmacoepidemiology and Treatment Science, Rutgers Institute of Health, Health Care Policy and Aging Research, New Brunswick, New Jersey, USA., Rudolph KE; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA. |
| Source: | Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2026 Jan; Vol. 35 (1), pp. e70304. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print Cited Medium: Internet ISSN: 1099-1557 (Electronic) Linking ISSN: 10538569 NLM ISO Abbreviation: Pharmacoepidemiol Drug Saf Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
